Page 2 - Heather Kirkham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heather kirkham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heather Kirkham Today - Breaking & Trending Today

Study tracks adherence to MS therapies in pregnant women, impact on hospitalizations

Senior Editor
Women with MS who continue their disease-modifying therapy, or DMT, throughout pregnancy have lower hospitalization costs and use, compared to those who discontinued their therapy.
That finding comes from a retrospective study conducted by Walgreens in collaboration with AllianceRx Walgreens Prime to understand how non-adherence to these women’s DMTs would impact healthcare cost and utilization over a two-year period. The researchers presented the findings on Feb. 26 at the virtual Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021.
MS is a chronic condition affecting the central nervous system that affects roughly 2.3 million people worldwide, with women affected two to three times as often as men. According to the National MS Society, none of the DMTs are approved for use during pregnancy yet discontinuing DMTs may cause relapse of disease. However, for certain DMTs, studies do indicate that some patients c ....

Francis Staskon , Heather Kirkham , Pharmacy Quality Alliance , National Ms Society , Americas Committee For Treatment , Research In Multiple Sclerosis Forum , Alliancerx Walgreens Prime , Americas Committee , Multiple Sclerosis Forum , Market Scan , ஹீத்தர் கர்க்ஹம் , மருந்தகம் தரம் கூட்டணி , தேசிய செல்வி சமூகம் , அமெரிக்காக்கள் குழு க்கு சிகிச்சை , ஆராய்ச்சி இல் பல ஸ்க்லரோசிஸ் மன்றம் , அள்ளிஅன்சர்ஸ் வால்க்ரீன்ஸ் ப்ரைம் , அமெரிக்காக்கள் குழு , பல ஸ்க்லரோசிஸ் மன்றம் , சந்தை ஊடுகதிர் ,

Study demonstrates adherence to disease-modifying therapies in pregnant MS patients can reduce hospitalization events

Share this article
Share this article
ORLANDO, Fla., March 1, 2021 /PRNewswire/ AllianceRx Walgreens Prime recently announced results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost. Researchers wanted to understand how non-adherence to their DMTs would impact healthcare cost and utilization over a two-year period. The findings suggest for those women continuing their therapy throughout pregnancy, hospitalization costs and use were lower, compared to those who discontinued their therapy. The retrospective study was conducted by Walgreens, in collaboration with AllianceRx Walgreens Prime, a leading specialty and home delivery pharmacy. ....

Francis Staskon , Heather Kirkham , Adrienne Foley , Pharmacy Quality Alliance , National Ms Society , Americas Committee For Treatment , Research In Multiple Sclerosis Forum , Alliancerx Walgreens Prime , Market Scan , Americas Committee , Multiple Sclerosis Forum , Prime Therapeutics , ஹீத்தர் கர்க்ஹம் , மருந்தகம் தரம் கூட்டணி , தேசிய செல்வி சமூகம் , அமெரிக்காக்கள் குழு க்கு சிகிச்சை , ஆராய்ச்சி இல் பல ஸ்க்லரோசிஸ் மன்றம் , அள்ளிஅன்சர்ஸ் வால்க்ரீன்ஸ் ப்ரைம் , சந்தை ஊடுகதிர் , அமெரிக்காக்கள் குழு , பல ஸ்க்லரோசிஸ் மன்றம் , ப்ரைம் சிகிச்சை ,